Skip to main content
. 2022 Aug 27;14(8):1562–1575. doi: 10.4254/wjh.v14.i8.1562

Table 6.

Studied miRNA associations with response to treatment according to modified response evaluation criteria in solid tumors

Response to treatment mRECIST
Stationary, n = 4 (5.7%)
Partial response, n = 7 (10.0%)
Complete response, n = 34 (48.6%)
Progressive disease, n = 6 (8.6%)
P value
miRNA-326 11.5 (2.1- 142.6) 31.1 (6.9- 209.4) 27.4 (10.0- 155.2) 69.6 (17.7- 197.9) 0.5
miRNA-511 3.8 (0.8- 10.5) 1.2 (0.3- 4.2) 1.0 (0.2- 1.5) 0.6 (0.1- 1.3) 0.05a
miRNA-424 4.9 (3.0- 8.6) 4.8 (2.1- 5.1) 5.4 (2.6- 13.1) 4.6 (3.1- 15.2) 0.8

mRECIST: Modified Response Evaluation Criteria in Solid Tumors.

a

P value < 0.05 is significant.